Sütő Gábor
II. Belgyógyászati Klinika és Nephrológiai Centrum, Pécsi Tudományegyetem, Orvostudományi Kar Pécs, Pacsirta u. 1., 7624.
Orv Hetil. 2019 Jun;160(22):855-860. doi: 10.1556/650.2019.31502.
Pain control in musculoskeletal disorders is still a challenging task. The most effective treatment of pain in autoimmune and immune-mediated diseases is the treatment of the disease itself. Analgesics, non-steroidal anti-inflammatory drugs and opioids are used to relieve pain. Analgesia is the central intervention of degenerative disorders. The most effective analgesic compounds are the non-steroidal anti-inflammatory drugs (NSAIDs). Concerns are raised regarding the safety of NSAIDs. There is not any organ which is not involved in adverse reactions, but the damage of the gastrointestinal system has been considered the most serious one for a long time. In the 21st century, the recognition of cardiovascular complications led to the re-evaluation of the role of these drugs in analgesia. Orv Hetil. 2019; 160(22): 855-860.
肌肉骨骼疾病的疼痛控制仍然是一项具有挑战性的任务。在自身免疫性和免疫介导性疾病中,最有效的疼痛治疗方法是治疗疾病本身。镇痛药、非甾体抗炎药和阿片类药物用于缓解疼痛。镇痛是退行性疾病的核心干预措施。最有效的镇痛化合物是非甾体抗炎药(NSAIDs)。人们对NSAIDs的安全性表示担忧。没有任何一个器官不涉及不良反应,但长期以来,胃肠道系统的损害被认为是最严重的。在21世纪,对心血管并发症的认识导致了对这些药物在镇痛中作用的重新评估。《匈牙利医学周报》。2019年;160(22): 855 - 860。